A citation-based method for searching scientific literature

Salomone Di Saverio, Fausto Catena, Donatella Santini, Luca Ansaloni, Tommaso Fogacci, Stefano Mignani, Antonio Leone, Filippo Gazzotti, Stefano Gagliardi, Angelo De Cataldis, Mario Taffurelli. Breast Cancer Res Treat 2008
Times Cited: 75







List of co-cited articles
538 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
436
45


A prognostic index for ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, P H Craig, J R Waisman, B S Lewinsky, W J Colburn, D N Poller. Cancer 1996
462
42



The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.
Onur Gilleard, Andrew Goodman, Martin Cooper, Mary Davies, Julie Dunn. World J Surg Oncol 2008
47
51

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
444
32

An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
Stephanie G MacAusland, Jaroslaw T Hepel, Frank K Chong, Shira L Galper, Jennifer S Gass, Robin Ruthazer, David E Wazer. Cancer 2007
60
36

The influence of margin width on local control of ductal carcinoma in situ of the breast.
M J Silverstein, M D Lagios, S Groshen, J R Waisman, B S Lewinsky, S Martino, P Gamagami, W J Colburn. N Engl J Med 1999
478
28

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
B Fisher, J Dignam, N Wolmark, D L Wickerham, E R Fisher, E Mamounas, R Smith, M Begovic, N V Dimitrov, R G Margolese,[...]. Lancet 1999
708
26


Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.
Lorie L Hughes, Molin Wang, David L Page, Robert Gray, Lawrence J Solin, Nancy E Davidson, Mary Ann Lowen, James N Ingle, Abram Recht, William C Wood. J Clin Oncol 2009
212
25

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
323
25

Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Julia S Wong, Carolyn M Kaelin, Susan L Troyan, Michele A Gadd, Rebecca Gelman, Susan C Lester, Stuart J Schnitt, Dennis C Sgroi, Barbara J Silver, Jay R Harris,[...]. J Clin Oncol 2006
164
24

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.
N Bijker, J L Peterse, L Duchateau, J P Julien, I S Fentiman, C Duval, S Di Palma, J Simony-Lafontaine, I de Mascarel, M J van de Vijver. J Clin Oncol 2001
351
22

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
Heather R MacDonald, Melvin J Silverstein, Helen Mabry, Brenda Moorthy, Wei Ye, Melinda S Epstein, Dennis Holmes, Howard Silberman, Michael Lagios. Am J Surg 2005
70
24


SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening.
Stefan O Emdin, Bengt Granstrand, Anita Ringberg, Kerstin Sandelin, Lars-Gunnar Arnesson, Hans Nordgren, Harald Anderson, Hans Garmo, Lars Holmberg, Arne Wallgren. Acta Oncol 2006
163
21


Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
505
20

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast.
Lars Holmberg, Hans Garmo, Bengt Granstrand, Anita Ringberg, Lars-Gunnar Arnesson, Kerstin Sandelin, Per Karlsson, Harald Anderson, Stefan Emdin. J Clin Oncol 2008
171
20


Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
202
20

Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
Lawrence J Solin, Alain Fourquet, Frank A Vicini, Marie Taylor, Ivo A Olivotto, Bruce Haffty, Eric A Strom, Lori J Pierce, Lawrence B Marks, Harry Bartelink,[...]. Cancer 2005
124
18

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
B Fisher, J Dignam, N Wolmark, E Mamounas, J Costantino, W Poller, E R Fisher, D L Wickerham, M Deutsch, R Margolese,[...]. J Clin Oncol 1998
606
18

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
211
17

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
232
17

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
388
17

The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
Fernando Tjin Asjoe, Sevilay Altintas, Manon T Huizing, Cecile Colpaert, Erik Van Marck, Jan B Vermorken, Wiebren A Tjalma. Breast J 2007
21
57

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
403
16

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
Andrew C Neuschatz, Thomas DiPetrillo, Margaret Steinhoff, Homa Safaii, Michael Yunes, Marcia Landa, Maureen Chung, Blake Cady, David E Wazer. Cancer 2002
87
14

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Karla Kerlikowske, Annette Molinaro, Imok Cha, Britt-Marie Ljung, Virginia L Ernster, Kim Stewart, Karen Chew, Dan H Moore, Fred Waldman. J Natl Cancer Inst 2003
174
14

Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials.
Gustavo A Viani, Eduardo J Stefano, Sérgio L Afonso, Lígia I De Fendi, Francisco V Soares, Paola G Leon, Flavio S Guimarães. Radiat Oncol 2007
63
17


Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Carlos Vargas, Larry Kestin, Nel Go, Daniel Krauss, Peter Chen, Neal Goldstein, Alvaro Martinez, Frank A Vicini. Int J Radiat Oncol Biol Phys 2005
75
14

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Min Yi, Funda Meric-Bernstam, Henry M Kuerer, Elizabeth A Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F Hwang, Jaime R Crow, Sheng Luo, Kelly K Hunt. J Clin Oncol 2012
88
14

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.
E Provenzano, J L Hopper, G G Giles, G Marr, D J Venter, J E Armes. Eur J Cancer 2003
89
13

An argument against routine use of radiotherapy for ductal carcinoma in situ.
Melvin J Silverstein. Oncology (Williston Park) 2003
36
27

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience.
Bruno Cutuli, Christine Cohen-Solal-le Nir, Brigitte de Lafontan, Hervé Mignotte, Virginie Fichet, Renaud Fay, Véronique Servent, Sylvia Giard, Claire Charra-Brunaud, Claire Lemanski,[...]. Int J Radiat Oncol Biol Phys 2002
90
13

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Sevilay Altintas, Kathleen Lambein, Manon T Huizing, Geert Braems, Fernando Tjin Asjoe, Hilde Hellemans, Eric Van Marck, Joost Weyler, Marleen Praet, Rudy Van den Broecke,[...]. Breast J 2009
33
30

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
231
13

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
98
13

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
318
13

Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience.
Merav A Ben-David, David E Sturtz, Kent A Griffith, Kathye R Douglas, James A Hayman, Allen S Lichter, Lori J Pierce. Breast J 2007
27
33

Ductal carcinoma in situ, complexities and challenges.
Gregory D Leonard, Sandra M Swain. J Natl Cancer Inst 2004
274
12


Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Arjan P Schouten van der Velden, Roel van Vugt, Jos A A M Van Dijck, Jan Willem H Leer, Theo Wobbes. Int J Radiat Oncol Biol Phys 2007
41
21

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status.
L J Solin, A Fourquet, F A Vicini, B Haffty, M Taylor, B McCormick, M McNeese, L J Pierce, C Landmann, I A Olivotto,[...]. Int J Radiat Oncol Biol Phys 2001
113
12

Trends in the treatment of ductal carcinoma in situ of the breast.
Nancy N Baxter, Beth A Virnig, Sara B Durham, Todd M Tuttle. J Natl Cancer Inst 2004
255
12

The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
Joan L Warren, Donald L Weaver, Therese Bocklage, Charles R Key, Charles E Platz, Kathleen A Cronin, Rachel Ballard-Barbash, Shawna C Willey, Linda C Harlan. Cancer 2005
52
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.